exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
$crsp announced it will present new clinical data at the 2022 european #hematology association eha congres regarding patients treated in climb-111 and climb-121 &amp; followed in climb-131 with ctx001 - now known as exa-cel - exagamglogene autotemcel. #crispr #biotech 
#Science - First and Foremost. Special interest in #CRISPR, #GeneEditing, #GeneTherapy ?? & #Ophthalmology. #Biotech, #Markets & #Stocks ??